File A11628 ("Insurance must cover experimental FDA-approved drugs") is before the New York Legislature and has not been decided. Latest step (July 29, 2026): In Assembly Committee.
New York file A11628, before the New York Legislature. Still to be decided as of 2026-07-29.
Skip insurance approval delays for experimental drugs If your doctor says an FDA-approved experimental drug could help you, your insurance must cover it immediately without making you wait for pre-approval.
Speeds up patient access to cutting-edge treatments Hospitals and doctors can offer more patients experimental medicines faster, which may shift how rare-disease and end-of-life care works in New York.
Insurance costs may rise, covering unproven drugs Insurers must pay for drugs that haven't completed full testing yet, which could increase premiums for all members and may cover treatments that don't actually work.
Requires insurance policies to provide coverage for federal food and drug administration approved expanded access to an investigational medical product that has been shown to be effective, without the need for any prior authorization determination.
Read the official record for A11628
See everything up for a vote · This week in New York · See what we have filed with the clerk